Showing results (51-60 of 80) with videos related to
Sort By:
Pageof 8
Cell Death & Disease|June 16, 2017
The NF-κB1 is a key regulator of acute but not chronic renal injuryAmy Fearn, Gerhard R Situmorang, Christopher Fox, et al.BMC Nephrology|August 5, 2025
Demographics and baseline disease characteristics of UK patients within the global aHUS registryRodney D Gilbert, Imad Al-Dakkak, Clare Boothe, et al.BMC Nephrology|April 12, 2019
Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational studyJan Menne, Yahsou Delmas, Fadi Fakhouri, et al.Biochimica Et Biophysica Acta. General Subjects|February 23, 2019
Heparan sulfate in chronic kidney diseases: Exploring the role of 3-O-sulfationLaura Ferreras, Anna Moles, Gerhard R Situmorang, et al.Transplantation|November 22, 2022
Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic SyndromeEmily K Glover, Kate Smith-Jackson, Vicky Brocklebank, et al.Cellular and Molecular Life Sciences : CMLS|January 9, 2023
Nitration of chemokine CXCL8 acts as a natural mechanism to limit acute inflammationSarah Thompson, Chong Yun Pang, Krishna Mohan Sepuru, et al.Clinical Kidney Journal|April 13, 2019
Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational studyJan Menne, Yahsou Delmas, Fadi Fakhouri, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 22, 2025
Cost-effectiveness of lifelong eculizumab versus disease monitoring of aHUSGiovany Orozco-Leal, Luke Vale, Yemi Oluboyede, et al.Journal of Hepatology|August 13, 2015
Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver diseaseCaroline L Wilson, Lindsay B Murphy, Jack Leslie, et al.JAMA Network Open|November 14, 2024
Donor Time to Death and Kidney Transplant Outcomes in the Setting of a 3-Hour Minimum Wait PolicySamuel J Tingle, Nicholas D H Chung, Abdullah K Malik, et al.Pageof 8